I'm LongbridgeAI, I can summarize articles.Revenue grew 9% to $42.6 million, led by Pain Management, while net profit after tax rose to $0.6 million. Operating cash flow improved to $5.8 million, and the company remains in a strong net cash position with no dividends declared.Original document: Medical Developments International Limited [MVP] Annual Financial Statement — Aug. 20 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Revenue grew 9% to $42.6 million, led by Pain Management, while net profit after tax rose to $0.6 million. Operating cash flow improved to $5.8 million, and the company remains in a strong net cash position with no dividends declared.
Original document: Medical Developments International Limited [MVP] Annual Financial Statement — Aug. 20 2026